Evidence map›Paper›PMID 34502518›Full record

ReviewInternational journal of molecular sciences2021

Ainhoa Pascual-Alonso, Antonio F Martínez-Monseny, Clara Xiol, Judith Armstrong

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Broadening the Phenotype Spectrum of MECP2 Variants in Men.Molecular genetics & genomic medicine · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ainhoa Pascual-AlonsoFundació Per la Recerca Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain.
Antonio F Martínez-MonsenyInstitut de Recerca Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain.
Clara XiolFundació Per la Recerca Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain.
Judith ArmstrongInstitut de Recerca Sant Joan de Déu, Santa Rosa 39-57, 08950 Esplugues de Llobregat, Spain.
Institut de Recerca Sant Joan de DéuSant Joan de Déu Research Foundation · ES

Funding

Government of Catalonia (Secretaria d'Universitats I Recerca) and the European Social Fund 2020 FI-B 00888Instituto de Salud Carlos III PI15/01159Instituto de Salud Carlos III PI20/00389Síndrome duplicación MECP2: Miradas que hablan" PFNR0085
6 · The paper itself

Abstract

Methyl CpG binding protein 2 (

Indexed as

Brain DiseasesCognitive DysfunctionGenetic Association StudiesGenotypeHumansMaleMethyl-CpG-Binding Protein 2MutationPhenotypeRett SyndromeX-Linked Intellectual DisabilityMECP2 protein, humanMethyl-CpG-Binding Protein 2encephalopathyloss-of-functionmalesMECP2MECP2 duplication syndromepoint mutationRett syndrome

Identifiers

PMID34502518
PMCPMC8431762
OpenAlexW3197327345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.